Extra-fine Formoterol/Beclomethasone in Asthmatic Crisis

• Status: Unknown status
• Trial end date: 2015-08-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to determine whether extra fine formoterol/beclomethasona are more effective in the treatment of asthmatic crisis when added to conventional treatment compared with conventional treatment alone.

• Phase: Phase 4
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: National Institute of Respiratory Diseases, Mexico
• Treatments: Albuterol; Beclomethasone; Formoterol Fumarate; Methylprednisolone; Methylprednisolone acetate; Methylprednisolone Hemisuccinate; Prednisolone; Prednisolone acetate; Prednisolone hemisuccinate; Prednisolone phosphate

Criteria

Inclusion Criteria:

• previous asthma diagnosis by physician

• spirometry with quality grade A, B or C

• presenting with asthmatic crisis in emergency room

Exclusion Criteria:

• imminent respiratory arrest

• respiratory comorbidities (COPD, cystic fibrosis, interstitial lung disease, pneumothorax, bronchiectasis)

• use of systemic steroids in 3 months previous

• allergy to steroids

• Peripheral capillary oxygen saturation (SpO2) less than 88%.